🇺🇸 FDA
Patent

US 10131668

Substituted imidazo[1,5-a]pYRAZINES for modulation of IRE1

granted A61PA61P1/16A61P11/00

Quick answer

US patent 10131668 (Substituted imidazo[1,5-a]pYRAZINES for modulation of IRE1) held by The Regents of the University of California expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P1/16, A61P11/00, A61P21/00, A61P25/00